HomeInsights52 Week High Stocks

Jubilant Pharmova Ltd 52 Week High

Jubilant Pharmova Ltd 52 Week High

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

7.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

YEARHIGH

₹ 1309

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Jubilant Pharmova Ltd is ₹ 1309 as of 22 Nov 24 .

Company Fundamentals for Jubilant Pharmova Ltd

No data available

Market Price of Jubilant Pharmova Ltd

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241141.2
21 Nov 20241130.85
19 Nov 20241131.1
18 Nov 20241145.1
14 Nov 20241166.9
13 Nov 20241145.45
12 Nov 20241189.65
11 Nov 20241225.45
08 Nov 20241236.95
07 Nov 20241256.35

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova to conduct board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

18 Oct 202410:41

News

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...

Read more

11 Sep 202410:52

News

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...

Read more

09 Sep 202412:00

News

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...

Read more

09 Sep 202414:30

News

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...

Read more

16 Aug 202418:41

News

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...

Read more

01 Aug 202414:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Jubilant Pharmova Ltd

What is the significance of Jubilant Pharmova Ltd reaching its 52-week high?

Jubilant Pharmova Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Jubilant Pharmova Ltd 52-week high?

Investors monitor Jubilant Pharmova Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Jubilant Pharmova Ltd a good buy when it hits its 52-week high?

Whether Jubilant Pharmova Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Jubilant Pharmova Ltd fundamentals.

What should I consider before investing in Jubilant Pharmova Ltd at its 52-week high?

Before investing in Jubilant Pharmova Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Jubilant Pharmova Ltd stock price continue to rise after reaching its 52-week high?

Jubilant Pharmova Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*